Skip to main content
Log in

The role of uric acid for predicting future metabolic syndrome and type 2 diabetes in older people

  • Published:
The journal of nutrition, health & aging

Abstract

Objective

Although it is known that high uric acid (UA) level is associated with type 2 diabetes (T2DM) and metabolic syndrome (MetS), most of the previous studies were focused on adults. Since aging becomes a major problem for many societies, in this longitudinal study, we investigated the role of UA in future T2DM and MetS in a large cohort of people who were older than 65 years.

Design

A cross-sectional and longitudinal study.

Setting/Participants

18,907 elderly (9,732 men, 9,175 women) aged above 65 years, enrolled from health check-up centers, were classified into three subgroups by 10-year intervals (young old 65-74 years, YO; old old 75-84 years, OO; and oldest old 85-94 years, ODO), with the average follow-up period of 4.3 years.

Measurements

The optimal cut-off values (CoVs) of baseline UA to predict future MetS and T2DM were determined by receiving operating characteristic (ROC) curve analysis. Using these CoVs of UA, the participants were divided into normal- and high-level groups of UA. Cox proportional hazard analysis was used to calculate hazard ratios (HRs) for the subjects with a high level of UA for the risk of future MetS and T2DM. In addition, Kaplan-Meier plots and log rank test were used to evaluate the time effect on the incidence of developing MetS and T2DM between the two groups.

Results

In ROC curve analysis, the optimal CoVs of baseline UA were 6.0, 6.3 and 6.7 mg/dl in YO, OO, and ODO men, respectively; 5.5 and 4.9 mg/dl in YO and OO women, respectively (all p < 0.05). However, the CoVs of UA in ODO women (6.1 mg/dl) failed to show its discriminant power (p = 0.13). The Cox regression analysis showed the YO subjects with a higher baseline level of UA had a higher risk of developing MetS (HRs 1.56 and 1.58 for men and women, respectively, both p < 0.001); as for T2DM the HRs were 1.39 and 1.57. In OO men, the HRs was 1.89 for developing future MetS. However, no significant findings could be noted in the ODO group. Kaplan-Meier plots and log rank test also showed the same findings.

Conclusion

Our study showed that old subjects with high levels of UA will have a higher chance to have MetS and T2DM, particularly in the YO group (6.0 mg/dl for men and 5.5 mg/dl for women, respectively). Using UA as one of the metabolic biomarkers may help clinicians to early detect and prevent MetS and diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Table 1
Table 2
Figure 2
Table 3
Table 4

Similar content being viewed by others

References

  1. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome—a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006 May;23(5):469–480. [PubMed: 16681555]

    CAS  PubMed  Google Scholar 

  2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001 May 16;285(19):2486–2497. [PubMed: 11368702]

    Article  Google Scholar 

  3. Hsiao AJ, Chen LH, and Lu TH. Ten leading causes of death in Taiwan: A comparison of two grouping lists. J Formos Med Assoc. 2015 Aug;114(8):679–680. [PubMed: 24457066]

    Article  PubMed  Google Scholar 

  4. Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004 Nov;27(11):2676–2681. [PubMed: 15505004]

    Article  PubMed  Google Scholar 

  5. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640–1645. [PubMed: 19805654]

    Article  CAS  PubMed  Google Scholar 

  6. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005 Nov 15;112(20):3066–3072. [PubMed: 16275870]

    Article  CAS  PubMed  Google Scholar 

  7. Hsueh JCT, Wang YT. Living arrangement and well-being of the elderly in Taiwan. Int J Welfare Aged. 2010;23:87–107.

    Google Scholar 

  8. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension. 2003 Jun;41(6):1183–1190. [PubMed: 12707287]

    Article  CAS  PubMed  Google Scholar 

  9. Perlstein TS, Gumieniak O, Williams GH, Sparrow D, Vokonas PS, Gaziano M, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension. 2006 Dec;48(6):1031–1036. [PubMed: 17060508]

    Article  CAS  PubMed  Google Scholar 

  10. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tatara K. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol. 2003;18(6):523–530. [PubMed: 12908717]

    Article  CAS  PubMed  Google Scholar 

  11. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS. Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism. 2006 Oct;55(10):1293–1301. [PubMed: 16979398]

    Article  CAS  PubMed  Google Scholar 

  12. Wang JY, Chen YL, Hsu CH, Tang SH, Wu CZ, Pei D. Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. J Pediatr. 2012 Oct;161(4):753-756.e2. [PubMed: 22575243]

    Google Scholar 

  13. Wang T, Bi Y, Xu M, Huang Y, Xu Y, Li X, et al. Serum uric acid associates with the incidence of type 2 diabetes in a prospective cohort of middle-aged and elderly Chinese. Endocrine. 2011 Aug;40(1):109–116. [PubMed: 21431449]

    Article  CAS  PubMed  Google Scholar 

  14. Dehghan A, van Hoek M, Sijbrands EJ, Hofman A, Witteman JC. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008 Feb;31(2):361–362. [PubMed: 17977935]

    Article  CAS  PubMed  Google Scholar 

  15. Report of a Joint Rural Health Advisory Committee and State Community Health Services Advisory Committee Work Group. Creating healthy communities for an aging population. Minnesota: Community and Family Health Division, Office of Rural Health and Primary Care and Office of Public Health Practice 2006.

  16. Health Promotion Administration, Ministry of Health and Welfare, Taiwan: Available from: http://wwwhpagovtw/BHPNet/Web/HealthTopic/TopicArticleaspx?No=200712250123&parentid=200712250023.

  17. Xu Y, Zhu J, Gao L, Liu Y, Shen J, Shen C, et al. Hyperuricemia as an independent predictor of vascular complications and mortality in type 2 diabetes patients: a metaanalysis. PLoS One. 2013 Oct 24;8(10):e78206. [PubMed: 24205159]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Liu Z, Que S, Zhou L, Zheng S. Dose-response Relationship of Serum Uric Acid with Metabolic Syndrome and Non-alcoholic Fatty Liver Disease Incidence: A Metaanalysis of Prospective Studies. Sci Rep. 2015 Sep 23;5:14325. [PubMed: 26395162]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012 May;59(3):235–242. [PubMed: 22398104]

    Article  PubMed  Google Scholar 

  20. Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, et al. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009 Sep;32(9):1737–1742. [PubMed: 19549729]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Johnson RJ, Nakagawa T, Sanchez-Lozada LG, Shafiu M, Sundaram S, Le M, et al. Sugar, Uric Acid, and the Etiology of Diabetes and Obesity. Diabetes. 2013 Oct;62(10):3307–3315. [PubMed: 24065788]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Feoli AM, Macagnan FE, Piovesan CH, Bodanese LC, Siqueira IR. Xanthine oxidase activity is associated with risk factors for cardiovascular disease and inflammatory and oxidative status markers in metabolic syndrome: effects of a single exercise session. Oxid Med Cell Longev. 2014;2014:587083. [PubMed: 24967004]

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation. 2007 May 15;115(19):2526–2532. [PubMed: 17470699]

    Article  CAS  PubMed  Google Scholar 

  24. Osgood K, Krakoff J, Thearle M. Serum uric acid predicts both current and future components of the metabolic syndrome. Metab Syndr Relat Disord. 2013 Jun;11(3):157–162. [PubMed: 23360433]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med. 2007 May;120(5):442–447. [PubMed: 17466656]

    Article  PubMed  Google Scholar 

  26. Goncalves JP, Oliveira A, Severo M, Santos AC, Lopes C. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine. 2012 Jun;41(3):450–457. [PubMed: 22350659]

    Article  CAS  PubMed  Google Scholar 

  27. Barbosa MC, Brandão AA, Pozzan R, Magalhães ME, Campana EM, Fonseca FL, et al. Association between uric acid and cardiovascular risk variables in a nonhospitalized population. Arq Bras Cardiol. 2011 Mar;96(3):212–218. [PubMed: 21271175]

    Article  CAS  PubMed  Google Scholar 

  28. Anton FM, Garcia Puig J, Ramos T, Gonzalez P, Ordas J. Sex differences in uric acid metabolism in adults: evidence for a lack of influence of estradiol-17 beta (E2) on the renal handling of urate. Metabolism. 1986 Apr;35(4):343–348. [PubMed: 3959904]

    Article  CAS  PubMed  Google Scholar 

  29. Abdelhafiz AH, Loo BE, Hensey N, Bailey C, Sinclair A. The U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life. Aging Dis. 2012 Dec;3(6):454–464. [PubMed: 23251851]

    PubMed  PubMed Central  Google Scholar 

  30. Hsu SP, Pai MF, Peng YS, Chiang CK, Ho TI, Hung KY. Serum uric acid levels show a 'J-shaped' association with all-cause mortality in haemodialysis patients. Nephrol Dial Transplant. 2004 Feb;19(2):457–462. [PubMed: 14736974]

    Article  CAS  PubMed  Google Scholar 

  31. Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, et al. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis. 2010 Mar;209(1):215–219. [PubMed: 19758590]

    Article  CAS  PubMed  Google Scholar 

  32. Abdelhafiz AH, Sinclair AJ. Low HbA1c and Increased Mortality Risk-is Frailty a Confounding Factor? Aging Dis. 2015 Aug 1;6(4):262–270. [PubMed: 26236548]

    Article  PubMed  PubMed Central  Google Scholar 

  33. Bray GA. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people. Adv Nutr. 2013 Mar 1;4(2):220–225. [PubMed: 23493538]

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. van Hoek M, Dehghan A, Witteman JC, van Duijn CM, Uitterlinden AG, Oostra BA, et al. Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes. 2008 Nov;57(11):3122–3128. [PubMed: 18694974 ]

    Article  PubMed  PubMed Central  Google Scholar 

  35. Volpato S, Bianchi L, Lauretani F, Lauretani F, Bandinelli S, Guralnik JM, et al. Role of muscle mass and muscle quality in the association between diabetes and gait speed. Diabetes Care. 2012 Aug;35(8):1672–1679. [PubMed: 22596176]

    Article  PubMed  PubMed Central  Google Scholar 

  36. Sedaghat S, Pazoki R, Uitterlinden AG, Hofman A, Stricker BH, Ikram MA, et al. Association of uric acid genetic risk score with blood pressure: the Rotterdam study. Hypertension. 2014 Nov;64(5):1061–1066. [PubMed: 25185132]

    Article  CAS  PubMed  Google Scholar 

  37. Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, et al. Plasma uric acid and the risk of type 2 diabetes in a Chinese community. Clin Chem. 2008 Feb;54(2):310–316. [PubMed: 18089655]

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chien-Ming Lin.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chang, JB., Chen, YL., Hung, YJ. et al. The role of uric acid for predicting future metabolic syndrome and type 2 diabetes in older people. J Nutr Health Aging 21, 329–335 (2017). https://doi.org/10.1007/s12603-016-0749-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-016-0749-3

Key words

Navigation